Macugen (pegaptanib) is a drug often prescribed to treat macular degeneration, a disorder related to the retina of the eye. Macugen is a Category B pregnancy drug, meaning that it has not been known to indicate any risk to individuals. Macugen is an ophthalmic anti-angiogenic, or vascular endothelial growth factor directed antibody used to slow the growth of blood vessels in the eye.
Drug Name: Macugen
Generic name: Pegaptanib sodium